Pharvaris PHVS
NASDAQ PHVS
$35.24 -0.42 (-1.18%)
As of: Sep 4, 2026 · 3:58 PM EDT

Pharvaris (PHVS) Current Taxes (2020 - 2026)

Pharvaris' (PHVS) quarterly Current Taxes came in at $1.1 million in Q1 2026, up 80.02% YoY from $624858.3 in Q1 2025, and up 2.67% on a QoQ basis from $1.1 million in Q4 2025.

Analysis

Pharvaris (PHVS) Current Taxes (2020 - 2026) Analysis & Trends

Pharvaris (PHVS) has 6 years of Current Taxes data on file, last reported at $1.1 million in Q1 2026.

  • Quarterly Current Taxes rose 80.02% year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 million (up 80.02% YoY) and the FY2025 annual result came in at $1.1 million, up 63.41% from the prior year.
  • Current Taxes improved to $1.1 million in Q1 2026, from $1.1 million in the prior quarter.
  • In the past five years, Current Taxes ranged from a high of $3.0 million in Q2 2022 to a low of $119109.2 in Q2 2024.
  • A 5-year average of $746515.4 and a median of $599267.8 in 2025 frame the typical range for Current Taxes.
  • Annual changes were most pronounced in 2023 — Current Taxes slumped 94.33% — and 2025, when it soared 451.85%.
  • Tracing PHVS's Current Taxes over 5 years: stood at $470642.2 in 2022, then slipped by 1.72% to $462570.2 in 2023, then soared by 38.9% to $642489.8 in 2024, then soared by 70.53% to $1.1 million in 2025, then rose by 2.67% to $1.1 million in 2026.
  • The last three Current Taxes figures came in at $1.1 million (Q1 2026), $1.1 million (Q4 2025), and $993121.7 (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Taxes (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 49.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 76.32 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Pharvaris 2.10 Bn 1.73 Bn 85,072.10 -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 1,124.86 Bn
Dec 31, 2025 1,095.61 Bn
Sep 30, 2025 993,121.65
Jun 30, 2025 657,304.09
Mar 31, 2025 624,858.28
Dec 31, 2024 642.49 Bn
Jun 30, 2024 119,109.15
Mar 31, 2024 573,677.23
Dec 31, 2023 462.57 Bn
Jun 30, 2023 169.76 Bn
Mar 31, 2023 378,080.36
Dec 31, 2022 470.64 Bn
Sep 30, 2022 388,235.02
Jun 30, 2022 2.99 Mn
Mar 31, 2022 144,460.58
Dec 31, 2021 144.32 Bn
Dec 31, 2020 19,181.56